DEVELOPING HOSPICE DRUG FORMULARY USING MULTI-ATTRIBUTE UTILITY THEORY (MAUT) METHODOLOGY

Author(s)

Nikhil G Khandelwal, MS, Doctoral Candidate1, Kem P Krueger, PhD, Associate Professor1, Bruce A Berger, PhD, Head of the Department1, Marc Carpenter, PhD, Associate Professor1, Beth Butz, MS, RPh, Pharmacy Director21Auburn University, Auburn, AL, USA; 2 Hospice of East Alabama Medical Center, Auburn, AL, USA

OBJECTIVES: With the increasing costs of providing pharmaceutical care, hospices in the U.S, are burdened with the high costs of providing optimum healthcare. There is a need to implement cost-containment strategies such as drug formulary at hospices that will aid in curbing pharmacy-related costs. While most hospices do not have a formulary, there are some that have a preferred drug list of most commonly used drugs, however, they lack appropriate methodology for the purpose of including particular drug(s) on the list. To develop rational hospice drug formulary based on scientific methodology. METHODS: This study was conducted at a hospice center located in the rural township of Alabama State. Multi-Attribute Utility Theory (MAUT) methodology was employed to develop a rational hospice drug formulary. MAUT is a systematic identification and analysis method that facilitates the P&T committee in selecting appropriate drugs on the basis of assessing important drug attributes such as efficacy, safety, cost, and dosage-form related parameters. For each therapeutic drug class, members of the P&T committee at the center ranked and weighted their preferences for different drug attributes that were considered most important for final drug selection process. The preference values were combined in a mathematical formula with the literature values that were obtained through comprehensive and systematic literature review process to yield total utility score values for individual drugs. Within each therapeutic class, final decisions to include particular drug on the formulary were made on the basis of total utility scores i.e. those drugs with highest total utility scores were selected for the formulary. RESULTS: The P&T committee at the hospice center successfully developed their drug formulary using MAUT methodology. CONCLUSION: The methods described and employed in this study can be used by P&T committees at other hospices for developing drug formularies at their respective centers.

Conference/Value in Health Info

2006-05, ISPOR 2006, Philadelphia, PA

Value in Health, Vol. 9, No.3 (May/June 2006)

Code

PCV34

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Formulary Development

Disease

Cardiovascular Disorders, Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×